NCT00079417
Clinical Trial Information
Trial Number: NCT00079417 (ClinicalTrials.gov)
Disease Type:
- Eye Neoplasm - Retinoblastoma
Trial Title:
Trial of Systemic Neoadjuvant Chemotherapy for Group B Intraocular Retinoblastoma
Study ID:
ARET0331
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
| Title | Description |
|---|---|
| NCT00079417-D3 | NCT00079417-D3 Only patients who are contributed to the analysis, that is, those with analysiset = 1 in the dataset NCT00079417-D1, are represented in the dataset. For each patient, ophthalmological response after 1 cycle and at the end of therapy are presented in the relevant column. The data presented in the second paragraph of Section 3.2 can be derived from the noted dataset. |
| NCT00079417-D2 | NCT00079417-D2 Only patients who are contributed to the analysis, that is, those with analysiset = 1 in the dataset NCT00079417-D1, are represented in the dataset. For each patient, the presence of each type of toxicity at any time during protocol therapy is identified in the relevant column. These data appear in section 3.3 of the manuscript. |
| NCT00079417-D1 | NCT00079417-D1 Blanks represent missing data or not applicable for analysis. The CONSORT diagram (manuscript Figure 2) can be reconstructed with the variable consort1 through consort4. The dataset contains one line for every patient enrolled on ARET0331. Table 1, Table 2, Figure 3 and the cumulative incidence calculations can be calculated from this data set. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®